Diabetes/Metabolism Research and Reviews

Cover image for Vol. 33 Issue 6

Edited By: Jesse Roth (Editor-in-Chief), Paolo Pozzilli (European Editor)

Impact Factor: 3.263

ISI Journal Citation Reports © Ranking: 2016: 61/138 (Endocrinology & Metabolism)

Online ISSN: 1520-7560

Author Guidelines

Diabetes/Metabolism Research and Reviews is an online-only journal publishing high quality original research and reviews in the fields of diabetes, endocrinology, metabolism and obesity. Original papers describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.

Submission is considered on the conditions that papers are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content, and all authors have also declared all competing interests; and that the work complies with Ethical Policies of the journal, and has been conducted under internationally accepted ethical standards after relevant ethical review. It is highly recommended you read this policy and complete any necessary documentation prior to your submission.

This journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works

Editorial Policies and Procedures

Acceptance of papers is based on the originality of the observation or investigation, the quality of the work described, the clarity of presentation, and the relevance to our readership. When submitting a manuscript it is with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and has not been submitted elsewhere for print or electronic publication consideration. The journal operates a stringent peer review process. All manuscripts will be reviewed by the Editors, members of the Editorial Board, or other expert reviewers. At the discretion of the Editors, the manuscript may be returned immediately without full review, if deemed not competitive or outside the realm of interests of the majority of the readership of the Journal. The decision (reject, invite revision, accept) letter will be conveyed through the Journal's ScholarOne Manuscripts system, coming directly from the Editor who has assumed responsibility for the manuscript's review. Editorial decisions are based not just on technical merit of the work, but also on other factors such as the priority for publication and the relevance to the Journal's general readership. All papers are judged in relation to other submissions currently under consideration. Rebuttals to rejected manuscripts are strongly discouraged and requests for resubmission of rejected manuscripts are generally not granted.

Publication ethics

Diabetes/Metabolism Research and Reviews is a member of the Committee on Publication Ethics and subscribes to its recommendations (Committee on Publication Ethics [COPE]: guidelines on good publication practice, www.publicationethics.org.uk). Best Practice Guidelines on Publication Ethics are also available from http://www.blackwellpublishing.com/publicationethics/ (Graf C, Wager E, Bowman A, et al., Int J Clin Pract 2007; 61 [suppl 152]: 126). The Editors reserve the right to reject a paper on ethical grounds. All authors are responsible for adhering to guidelines on good publication practice.

No paper can be published in the Journal unless it meets all of these requirements.


Reviews are typically invited, but authors are welcome to contact the Editorial office with proposals for potential reviews. There is no set word limit for reviews and there is no need for the abstract to be structured.

Manuscript style

Manuscripts should be prepared in 12-point type in one of the standard fonts: Times, Helvetica, or Courier are preferred. It is not necessary to double line space your manuscript. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be prepared and uploaded as separate figure files.

The language of the journal is English. If you are not a native English speaker, we strongly recommend that you have your manuscript professionally edited before submission. Authors should note that the journal is unable to accept a manuscript unless the reviewers and Editors agree that the quality of the grammar, spelling, and punctuation are adequate and that there is full clarity of meaning throughout, with no ambiguity. As part of our Author Services, Wiley-Blackwell suggests a number of English language editing companies that authors can contact to arrange to have their manuscript edited.

Key points to note:
  • The cover page should include the full title, short title of up to 40 characters and names and affiliations of all authors. Give the full address, including email, telephone and fax, of the author who is to check the proofs.
  • Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant number(s) .
  • Authors may suggest appropriate reviewers, for consideration by the Editors.
  • Please bear in mind the importance of the title and abstract; these will be read many more times than the full paper, and are used by readers to decide if they will read the full paper or not. It is worth taking time to make the title and abstract as informative and accurate as possible. For advice on writing titles and abstracts please visit our Author Services site.
  • Enter an abstract of up to 250 words for all articles. An abstract is a concise summary of the whole paper, not just the conclusions, and is understandable without reference to the rest of the paper. It should contain no citation to other published work. Divide the abstract into four short paragraphs labelled Background, Methods, Results, Conclusions.
  • Include up to six keywords that describe your paper for indexing purposes.
  • Manuscripts should be structured into headed sections as follows: Title, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References. Other subsection headings within the main headings may be used but should be limited.
  • Abbreviations are not encouraged except for units of measurement and universally recognized abbreviations (e.g. DNA). When an abbreviation appears in the text for the first time, it should be placed in parentheses after the words for which it stands. We strongly discourage the use of non-standard abbreviations, as they are not helpful to readers.
  • Compound and drug names. Generic names should be used for all compounds. Trade names may be used in parentheses after the generic name. Sources of unusual materials and chemicals, and the manufacturer and model of equipment used should be indicated.

The Editor reserves the right to alter manuscripts whenever necessary to make them conform to the stylistic and bibliographical conventions of the Journal.


All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:

a) Journal article

1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, and inferior olivary to two paravermal cortical zones of the cat cerebellum. J Comp Neurol. 1998;39:537-551.

b) Chapter in a book

2. Jupiter KC, Ringer DC. Nonhuman Primates. In: Fond MG, Sanders CC, Loewen FM, eds. Laboratory Animal Medicine. San Diego: Academic Press; 2002:675–791.

c) Book

3. Voet D, Voet JG. A Population-based Policy and Systems Changed Approach. New York: John Wiley & Sons; 1990.

d) Website references

4. Groove KJ. Primate Factsheets 2010. http://pin.primates.12345.wisc.edu/factsheets/. Accessed November 21, 2015.

Journal title abbreviations should conform to the practices of Chemical Abstracts.

For more information, please see the AMA Manual of Style


Upload each figure as a separate file in either .tiff or .eps format, with the figure number and the top of the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each figure and set of figures. Where a key to symbols is required, please include this in the artwork itself, not in the figure legend. All illustrations must be supplied at the correct resolution:

  • Black and white and colour photos - 300 dpi
  • Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum
  • Combinations of photos and drawings (black and white and colour) - 500 dpi

Tables should be part of the the main document and should be placed after the references. If the table is created in excel the file should be uploaded separately.

Please note that since this journal is published online-only, there are no charges for colour figures.

Manuscript Submission

Diabetes/Metabolism Research and Reviews operates an online submission and peer review system that allows authors to submit articles and track their progress online. Please read the remainder of these instructions to authors and then click http://mc.manuscriptcentral.com/dmrr to navigate to the site. All papers must be submitted via the online system.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year you will have an account.

File types. Preferred formats for the text and tables of your manuscript are .doc, .rtf, .ppt, .xls. Figures may be provided in .tiff or .eps format.

Editable source files for all parts of your manuscript must be uploaded. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files. Any supplementary material, such as large raw data files, must be uploaded as separate files and designated as "Supplementary Material for Review".
Revised manuscript submissions should include a point by point letter specifying how the author has responded to the reviewers' and editors' comments.

For all submission enquiries please contact the DMRR Editorial Office, e-mail: DMRRoffice@wiley.com

Permissions. Please ensure that you have permission from the copyright holder to use any figures or materials in your manuscript that were taken from previously published work (in print or online). Most major publishers now use RightsLink, the electronic permissions system, to grant permissions using direct links from the article of interest, but for publishers/copyright holders who do not use this system, please use our Permissions Request Form to request permission and upload the completed form along with your manuscript.


If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp.

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution License OAA
  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyri ght--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

Submission of a manuscript will be held to imply that it contains original unpublished work that is not being submitted or considered for publication elsewhere at the same time. Submitted material will not be returned to the author, unless specifically requested.

Post Acceptance


For accepted manuscripts the publisher will supply proofs to the submitting author prior to publication. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of a delay to publication.


This journal now uses eLocators. For more information, please visit the Author Services eLocator page here.


Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many benefits the service offers.

Author Services

If your manuscript has been accepted for publication, explore our suite of tools and services for authors and sign up for:

  • Article Tracking
  • E-mail Publication Alerts
  • Personalization Tools

Accepted Articles

Peer reviewed articles that have been accepted for publication in Diabetes/Metabolism Research and Reviews are now rapidly published online before being copy-edited and typeset. The articles are published on the Accepted Articles page of the journal website, as PDFs, with a *DOI (digital object identifier), so they can be cited. Subsequently, the full copy-edited and typeset articles will appear in an online issue, after proofing by the authors.

Readers should note that the versions of articles published within Accepted Articles should not be considered the version of record. Wiley-Blackwell cannot be held responsible for errors or consequences arising from the use of information contained in these articles.

*The Digital Object Identifier (DOI) is an identification system for intellectual property in the digital environment. Developed by the International DOI Foundation on behalf of the publishing industry, its goals are to provide a framework for managing intellectual content, link customers with publishers, facilitate electronic commerce, and enable automated copyright management.

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Note to NIH and HHMI Grantees

Wiley-Blackwell has agreed to automatically send the accepted version of contributions authored by NIH grant-holders or HHMI fundees to PubMed Central. The accepted version will be made publicly available 12 months after publication for NIH grant-holders and 6 months after publication for HHMI fundees. Further information on these services is available here.

Authority and Responsibility

The intellectual content of the paper is the responsibility of the authors. The Editors and the Publisher accept no responsibility for opinions and statements of authors. While every effort will be made by the Editor and Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information. The authors agree to keep the Editors and Publisher fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.